And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Dermwire News

News | July 15, 2020

Arcutis’ Roflumilast Cream Could Be “Game Changer” for Plaque Psoriasis

Arcutis Biotherapeutics, Inc.’s Roflumilast cream (ARQ-151) produced significant improvements in patients with plaque psoriasis in as early as two weeks, according to a results from a phase 2b trial published in The New England...

Read More

News | July 15, 2020

Arcutis Initiates Patient Enrollment in Phase 2b Study in Chronic Hand Eczema

Arcutis Biotherapeutics, Inc. initiated enrollment in the Phase 2b portion of the Phase 1/2b study of ARQ-252, a potent and highly selective topical small molecule inhibitor of Janus kinase type 1 (JAK1), in adult patients with chronic hand...

Read More

News | July 14, 2020

High Kissability Marks for Restylane Kysse in New Phase 4 Study

In a recent first-of-its-kind phase IV, Kissability study for an injectable hyaluronic acid (HA) lip filler, subject satisfaction as well as partner satisfaction were evaluated following treatment with Restylane Kysse. Many consumers...

Read More

News | July 13, 2020

Cutera Launches Fraxis PRO

Cutera, Inc. is launching Fraxis PRO progressive dermal remodeling technology. Fraxis PRO combines fractional CO2 for skin resurfacing and radiofrequency microneedling for dermal remodeling in a single device. Fraxis PRO...

Read More

News | July 10, 2020

Azitra Awarded Patent for Engineered Bacterial Strain Discovery Platform

Azitra, Inc. has been issued a patent for the company’s engineered bacterial strain discovery platform. The United States Patent and Trademark Office (USPTO) has issued US Patent No. 10,702,558, which includes broad composition of...

Read More

Advertisement

The Latest News

Advertisement

View more